Descending
|
03/05/2010 Michael J. Fox Receives Honorary Doctorate from Karolinska Institute
Karolinska awards honorary doctorates to people who have not earned a PhD through formal academic achievements, but who have benefited research through other means.
03/02/2010 MJFF Commits up to $5.75 Million in Funding for 2010 Critical Challenges in Parkinson's Disease
Two Challenges aim to streamline efforts focused on genetic targets alpha-synuclein and LRRK2. The third will drive collaborations that maximize the resources of the Brain & Body Donation Program at the Arizona Parkinson’s Disease Consortium.
Researchers will evaluate the disease-modifying potential of transdermal nicotine using standard skin patches of the type used by millions of smokers as a quitting aid.
02/17/2010 MJFF Awards $3.5 Million to Advance LRRK2 Therapeutic Development Efforts
Using a multipronged approach that includes collaboration between the research teams, the funded projects will help advance understanding of the LRRK2 gene.
Strategic investment in new research technologies and tools is critical to attaining transformative new treatments that will make a tangible impact on patients’ lives.
02/04/2010 MJFF Awards $2.8 Million to Drive Development of Parkinson's Disease Biomarker Pipeline
The discovery of PD biomarkers, physiological characteristics that can be objectively measured and evaluated by researchers, are critical to PD drug development.
Three teams will focus on inflammation and oxidative stress, two will target alpha-synuclein, and one will investigate HDACs, a family of enzymes shown to enhance expression of potential protective factors in preclinical PD models.
